Risk factors for diabetic retinopathy in people with Type 2 diabetes: A case-control study in a UK primary care setting

Primary Care Diabetes

Volumn 10, Issue 4, 2016, Pages 300-308

  Martín Merino, Elisa ^a,e   Fortuny, Joan ^b   Rivero Ferrer, Elena ^b   Lind, Marcus ^c,d   Garcia Rodriguez, Luis Alberto ^a  

^a Centro Español de Investigación Farmacoepidemiológica ^*  (Spain)

^b Global Epidemiology   (Spain)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d NU Hospital Organization   (Sweden)

^e Division de Farmacoepidemiologia y Farmacovigilancia   (Spain)

Author keywords

Case control study; Diabetic retinopathy; Primary care; Risk factors; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; SMOKING; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; ADVERSE EFFECTS; BLOOD; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DRINKING BEHAVIOR; FACTUAL DATABASE; INCIDENCE; MIDDLE AGED; ODDS RATIO; PRIMARY HEALTH CARE; PROTECTION; RETINAL VEIN OCCLUSION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLAUCOMA; HUMANS; INCIDENCE; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PRIMARY HEALTH CARE; PROTECTIVE FACTORS; RETINAL VEIN OCCLUSION; RISK ASSESSMENT; RISK FACTORS; UNITED KINGDOM;

EID: 84976460447     PISSN: 17519918     EISSN: 18780210     Source Type: Journal    
DOI: 10.1016/j.pcd.2016.01.002     Document Type: Article

References (31)

1. C. Bunce, and R. Wormald Causes of blind certifications in England and Wales: April 1999-March 2000 Eye (Lond) 22 2008 905 911
2. Blindness caused by diabetes - Massachusetts, 1987-1994 Morb. Mortal. Wkly. Rep. 45 1996 228 238
3. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
4. C.B. Meyerle, E. Chew, and F.L. Ferris III. Nonproliferative diabetic retinopathy E. Duh, Contemporary Diabetes: Diabetic Retinopathy 2008 Humana Press Totowa, NJ 3 28
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N. Engl. J. Med. 329 1993 977 986
6. THIN Data Statistics Cegedim Strategic Data Medical Research UK 2015 Available at: http://csdmruk.cegedim.com (accessed 02.02.16)
7. B.T. Blak, M. Thompson, H. Dattani, and A. Bourke Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates Inform. Prim. Care 19 2011 251 255
8. C.D. Stuart-Buttle, J.D. Read, H.F. Sanderson, and Y.M. Sutton A language of health in action: read codes, classifications and groupings Proc. AMIA Annu. Fall Symp. 7 1996 5 79
9. Multilex for primary care 2015 First DataBank Europe Available at: http://www.fdbhealth.co.uk/multilex/ (accessed 02.02.16)
10. E. Martin-Merino, J. Fortuny, E. Rivero, and L.A. Garcia-Rodriguez Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database Diabetes Care 35 2012 762 767
11. E. Martín-Merino, J. Fortuny, E. Rivero-Ferrer, and L.A. García-Rodríguez Incidence of retinal complications in a cohort of newly diagnosed diabetic patients PLOS ONE 9 2014 e100283
12. L.S. Lim, E. Lamoureux, S.M. Saw, W.T. Tay, P. Mitchell, and T.Y. Wong Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology 117 2010 524 530
13. Guidelines for Diabetic Retinopathy. The Royal College of Ophthalmologists. Scientific Department. Screening for diabetic retinopathy 2005 35 39
14. T.J. Lyons, A.J. Jenkins, D. Zheng, D.T. Lackland, D. McGee, W.T. Garvey, and et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort Invest. Ophthalmol. Vis. Sci. 45 2004 910 918
15. I.M. Stratton, E.M. Kohner, S.J. Aldington, R.C. Turner, R.R. Holman, S.E. Manley, and et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis Diabetologia 44 2001 156 163
16. A. Ruigomez, and L.A. Garcia Rodriguez Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor Eur. J. Epidemiol. 14 1998 439 445
17. P.A. Ozer, N. Unlu, M.N. Demir, D.O. Hazirolan, M.A. Acar, and S. Duman Serum lipid profile in diabetic macular edema J. Diabetes Complic. 23 2009 244 248
18. I. Zib, and P. Raskin Novel insulin analogues and its mitogenic potential Diabetes Obes. Metab. 8 2006 611 620
19. M.D. Davis, R.W. Beck, P.D. Home, J. Sandow, and F.L. Ferris Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin Exp. Clin. Endocrinol. Diabetes 115 2007 240 243
20. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
21. O. Pedersen, and P. Gaede Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study Metabolism. 52 2003 19 23
22. I. Ranjit Unnikrishnan, R.M. Anjana, and V. Mohan Importance of controlling diabetes early - the concept of metabolic memory, legacy effect and the case for early insulinisation J. Assoc. Physicians India 59 Suppl. 2011 8 12
23. I.M. Stratton, C.A. Cull, A.I. Adler, D.R. Matthews, H.A. Neil, and R.R. Holman Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75) Diabetologia 49 2006 1761 1769
24. D.R. Matthews, I.M. Stratton, S.J. Aldington, R.R. Holman, and E.M. Kohner Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69 Arch. Ophthalmol. 122 2004 1631 1640
25. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group Br. Med. J. 317 1998 703 713
26. D.J. Newman, M.B. Mattock, A.B. Dawnay, S. Kerry, A. McGuire, and M. Yaqoob Systematic review on urine albumin testing for early detection of diabetic complications Health Technol. Assess. 9 2005 iii-vi, xiii-163
27. R. Klein, B. Zinman, R. Gardiner, S. Suissa, S.M. Donnelly, and A.R. Sinaiko The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in Type 1 diabetic patients. The renin-angiotensin system study Diabetes 54 February (2) 2005 527 533
28. R. Klein, B.E. Klein, and M.D. Davis Is cigarette smoking associated with diabetic retinopathy? Am. J. Epidemiol. 118 1983 228 238
29. S. Wang, J.J. Wang, and T.Y. Wong Alcohol and eye diseases Surv. Ophthalmol. 53 2008 512 525
30. S. Colagiuri, C.A. Cull, and R.R. Holman Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? U.K. prospective diabetes study 61 Diabetes Care 25 2002 1410 1417
31. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group N. Engl. J. Med. 342 2000 381 389